Axsome Therapeutics Inc <AXSM.O>: Mizuho cuts target price to $306 from $310
AXSM•Related News
RBC Bearings Q1 Adjusted EPS USD 3.88 Vs. IBES Estimate USD 3.43
RBC•
AbbVie Q2 GAAP EPS climbs 290.4% to $2.03; net revenues rise 10.2% to $16.99 billion vs Q2 FY25
ABBV•
Faeth Therapeutics, Inc <FTH.O>: Raymond James initiates coverage with outperform rating; price target $56
FTH•
Guardant Health Inc <GH.O>: Leerink Partners Raises Target Price to $225 From $190
GH•
Imperial Oil declares Q3 2026 dividend of 87 cents per share
IMO•